4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-25-001709
Director sold 5,739 shares at $75.86 ($435,371)
- Director acquired 5,739 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STONE HEISZ LESLIE · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-13 | Exercise or conversion : show line 1 in the form | +5,739 | $45.32 | $260,073 | 35,774 | D |
| 2025-02-13 | Sale : show line 2 in the form | −5,739 | $75.86 | $435,371 | 30,035 | D |
| Open-market sales · 5,739 sh · avg $75.86 · $435,371 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-13 | Exercise or conversion : show line 3 in the form Director Stock Option (Right to Acquire) | −5,739 | 0 | D |
Loading xslF345X05/doc4.xml…